AC
DGX icon

Alexandria Capital’s Quest Diagnostics DGX Stock Holding History

Alexandria Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23
Closed -$2K – 300
2017
Q3 		$2K Sell
23
-6
-21% -$637 ﹤0.01% 502
2017
Q2 		$3K Hold
29
– – ﹤0.01% 528
2017
Q1 		$3K Hold
29
– – ﹤0.01% 519
2016
Q4 		$3K Hold
29
– – ﹤0.01% 516
2016
Q3 		$2K Sell
29
-2
-6% -$168 ﹤0.01% 545
2016
Q2 		$3K Buy
+31
New +$2.36K ﹤0.01% 522

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alexandria Capital's DGX Position: Q4 2017 in Review

Alexandria Capital sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 23 shares — an estimated $2K sold.

Alexandria Capital first reported a position in DGX in Q2 2016 and held it in 6 quarters. The position peaked at $3K in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Alexandria Capital reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 23 Quest Diagnostics shares in Q4 2017, an estimated $2K.
  • Alexandria Capital first reported a position in Quest Diagnostics in Q2 2016 and held it in 6 quarters.
  • Alexandria Capital's Quest Diagnostics position peaked at $3K in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.